The case for leaving out A1 beta-casein - QI&CPD - Category 2

Duration

1 hr

Profession

Physician

# of Credits

2.0

Accreditation

QI & CPD - Category 2

Expiry Date

2021-05-02

This is a 4-part Clinical Brief series that has been accredited with RACGP. Participants must read all 4 issues and then complete the questions on Issue 4 to claim CPD points.

This activity has been approved by The Royal Australian College of General Practitioners QI&CPD Program. Total Points: 2.00 Point(s) (Category 2)

Damian Flanagan
MBBS, MWell, DipRACOG
South Coast Medical
Blairgowrie, Victoria, Australia

On completion of this program, participants will be better able to:

  1. Evaluate the evidence regarding the effects of A1 beta-casein on digestion
  2. Recognise that many people with self-reported milk intolerance may have milk-related gastrointestinal symptoms due to ingestion of A1 beta-casein, as opposed to lactose intolerance
  3. Analyse the evidence on the association between A1 beta-casein and non-communicable diseases such as type 1 diabetes and cardiovascular disease
  4. Review the alternatives to A1 beta-casein and their safety


Related Courses